Literature DB >> 18384477

Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram.

Roland N Ndip1, Alertia E Malange Takang, Juliet E A Ojongokpoko, Henry N Luma, Agnes Malongue, Jane-Francis T K Akoachere, Lucy M Ndip, Martin MacMillan, Lawrence T Weaver.   

Abstract

OBJECTIVE: To determine the prevalence of Helicobacter pylori in patients with gastro-duodenal pathologies and the susceptibility patterns of isolates to the currently recommended antibiotic treatment regimen used in Cameroon.
METHODS: Consecutive dyspeptic patients referred to Douala General Hospital, Cameroon for endoscopy were recruited in the study. Gastric biopsies were collected from the patients and H. pylori isolated and identified following standard microbiology and biochemical techniques. Antibiotic susceptibility was determined by disk diffusion and agar dilution methods against clarithromycin, tetracycline, amoxicillin and metronidazole. Data were analysed using chi-square test and significance considered at P < 0.05.
RESULTS: Seventy-one (92.2%) of the 77 patients (mean age 44.5 +/- 15.7, range 15-77 years) were positive for H. pylori. The antibiotic susceptibility rates were 56% for tetracycline, 55.3% for clarithromycin, 14.4% for amoxicillin and 6.8% for metronidazole. The prevalence of clarithromycin resistance in males vs. females was 42.1%vs. 46.7%, while for metronidazole it was 89.5%vs. 94.7% (P > 0.05). Antimicrobial susceptibility results also revealed 12 antibiotypes based on resistance to the antimicrobial agents investigated. The resistance pattern, amoxicillin and metronidazole (AMR(R) MET(R)) was the most common (23.7%) amongst the isolates. More than 60% of the isolates exhibited multi-drug resistance to three or four antibiotics.
CONCLUSION: Multi-drug resistance is common against the current treatment regimen in Cameroon and, therefore, calls for urgent studies involving newer and broad spectrum antibiotics to address the problem.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384477     DOI: 10.1111/j.1365-3156.2008.02062.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  23 in total

1.  Stool Antigen Testing, a Reliable Noninvasive Method of Assessment of Helicobacter pylori Infection Among Patients with Gastro-duodenal Disorders in Cameroon.

Authors:  Laure Brigitte Kouitcheu Mabeku; Mohamadou Bello Epesse; Stephane Fotsing; Roland Kamgang; Magloire Tchidjo
Journal:  Dig Dis Sci       Date:  2020-04-30       Impact factor: 3.199

2.  Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of Helicobacter pylori.

Authors:  N F Tanih; L M Ndip; R N Ndip
Journal:  Ann Trop Med Parasitol       Date:  2011-04

3.  Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.

Authors:  V Y Miendje Deyi; V Y Miendje Deyi; P Bontems; J Vanderpas; E De Koster; R Ntounda; C Van den Borre; S Cadranel; A Burette
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

4.  Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.

Authors:  Laura Cerqueira; Ricardo M Fernandes; Rui M Ferreira; Mónica Oleastro; Fátima Carneiro; Catarina Brandão; Pedro Pimentel-Nunes; Mário Dinis-Ribeiro; Céu Figueiredo; Charles W Keevil; Maria J Vieira; Nuno F Azevedo
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

5.  Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.

Authors:  Ousman Secka; Douglas E Berg; Martin Antonio; Tumani Corrah; Mary Tapgun; Robert Walton; Vivat Thomas; Juan J Galano; Javier Sancho; Richard A Adegbola; Julian E Thomas
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

Review 6.  Treatment of Helicobacter pylori infection: current status and future concepts.

Authors:  Jyh-Chin Yang; Chien-Wei Lu; Chun-Jung Lin
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

7.  Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.

Authors:  Abdoulaye Seck; Christophe Burucoa; Daouda Dia; Mouhamadou Mbengue; Manuella Onambele; Josette Raymond; Sebastien Breurec
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-01-08       Impact factor: 3.944

8.  Aqueous and organic solvent-extracts of selected south African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: inhibitory and bactericidal potential.

Authors:  Collise Njume; Afolayan A Jide; Roland N Ndip
Journal:  Int J Mol Sci       Date:  2011-09-02       Impact factor: 5.923

9.  Inhibitory and bactericidal potential of crude acetone extracts of Combretum molle (Combretaceae) on drug-resistant strains of Helicobacter pylori.

Authors:  Collise Njume; Anthony J Afolayan; Amidou Samie; Roland N Ndip
Journal:  J Health Popul Nutr       Date:  2011-10       Impact factor: 2.000

10.  Phytochemical analysis and antibacterial evaluation of the ethyl acetate extract of the stem bark of Bridelia micrantha.

Authors:  Anthonio O Adefuye; Roland N Ndip
Journal:  Pharmacogn Mag       Date:  2013-01       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.